Next-Generation Sequencing (NGS) is a cutting-edge technology that is indispensable to providing the most accurate, complete, and tailored diagnostic information to clinicians for clinical care. NGS allows Pathology Reports to be created that are critical to the diagnosis, personalized treatment, and monitoring of cancer, and has become the Gold Standard of personalized care.
NGS is also revolutionizing clinical research and public health monitoring, speeding our understanding of disease, and allowing us to develop new and effective interventions quickly. Our team of scientists has decades of collective experience working with multi-cellular diagnostics to discover specific answers to complex molecular questions involving both DNA and RNA.
Our NGS expertise extends to both solid-tumor and hematologic diseases, and our clinical pathology staff and network, coupled with our deep experience, allow us to automate and deploy the most sophisticated assays for clinical diagnostics. Moreover, our world-class bioinformatics give us the unique capability to provide actionable reports for clinicians as well as create robust data structures to receive, store, and analyze data. Our advanced and proprietary informatics and analytics allow us to provide insights and highly tailored actionable reports. Coupled with our harmonized chemistries and highly automated processes within the laboratory, we can scale indefinitely while maintaining the best-in-class turn-around-times.
Cyx Solid Tumor 505
Cyx Solid Tumor 505 enables rapid and actionable genomic insights for all patients
with advanced cancer. FDA-cleared and CE-IVD-marked comprehensive tumor
profiling affords every patient access to personalized treatment options.
Quantitative Polymerase Chain Reaction (qPCR)
Quantitative Polymerase Chain Reaction (qPCR) is a powerful, cost-effective, efficient, reliable, and rapid technology used in real-time to detect and quantify naturally occurring and mutated nucleic acids (DNA/RNA) present in a specimen. qPCR has widespread applications in clinical diagnostics.
UTI – PCR Pathogen Identification & Resistance Gene Detection
We can detect bacteria in a higher number of symptomatic patients than with urine culture. PCR can also detect more polymicrobial infections compared to urine culture.